[go: up one dir, main page]

PL2034956T3 - Kompozycje zawierające glikozaminoglikany o niskiej lepkości oraz zastosowanie wspomnianej kompozycji w leczeniu przewlekłego zapalenia pęcherza - Google Patents

Kompozycje zawierające glikozaminoglikany o niskiej lepkości oraz zastosowanie wspomnianej kompozycji w leczeniu przewlekłego zapalenia pęcherza

Info

Publication number
PL2034956T3
PL2034956T3 PL07729534T PL07729534T PL2034956T3 PL 2034956 T3 PL2034956 T3 PL 2034956T3 PL 07729534 T PL07729534 T PL 07729534T PL 07729534 T PL07729534 T PL 07729534T PL 2034956 T3 PL2034956 T3 PL 2034956T3
Authority
PL
Poland
Prior art keywords
glycosaminoglycans
therapy
compositions
composition
low viscosity
Prior art date
Application number
PL07729534T
Other languages
English (en)
Other versions
PL2034956T5 (pl
Inventor
Giorgio Zoppetti
Nadia Puppini
Marco Pizzutti
Original Assignee
Altergon S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38617962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2034956(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon S.A. filed Critical Altergon S.A.
Publication of PL2034956T3 publication Critical patent/PL2034956T3/pl
Publication of PL2034956T5 publication Critical patent/PL2034956T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL07729534.3T 2006-05-26 2007-05-25 Kompozycje zawierające glikozaminoglikany o niskiej lepkości oraz zastosowanie wspomnianej kompozycji w leczeniu przewlekłego zapalenia pęcherza PL2034956T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001030A ITMI20061030A1 (it) 2006-05-26 2006-05-26 Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
PCT/EP2007/055107 WO2007138014A1 (en) 2006-05-26 2007-05-25 Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
EP07729534.3A EP2034956B2 (en) 2006-05-26 2007-05-25 Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis

Publications (2)

Publication Number Publication Date
PL2034956T3 true PL2034956T3 (pl) 2018-08-31
PL2034956T5 PL2034956T5 (pl) 2023-08-07

Family

ID=38617962

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07729534.3T PL2034956T5 (pl) 2006-05-26 2007-05-25 Kompozycje zawierające glikozaminoglikany o niskiej lepkości oraz zastosowanie wspomnianej kompozycji w leczeniu przewlekłego zapalenia pęcherza

Country Status (12)

Country Link
US (1) US8252770B2 (pl)
EP (1) EP2034956B2 (pl)
JP (1) JP5177446B2 (pl)
CA (1) CA2653369C (pl)
DK (1) DK2034956T4 (pl)
ES (1) ES2664951T5 (pl)
FI (1) FI2034956T4 (pl)
HU (1) HUE037542T2 (pl)
IT (1) ITMI20061030A1 (pl)
PL (1) PL2034956T5 (pl)
TR (1) TR201808687T4 (pl)
WO (1) WO2007138014A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITMI20130075A1 (it) 2013-01-21 2014-07-22 Altergon Sa Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
IL312865B2 (en) 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
AU2015325055B2 (en) * 2014-10-01 2021-02-25 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
EP3512561A4 (en) 2016-09-16 2020-10-07 Glycologix, LLC SULFATED GLYCOSAMINOGLYCAN BIOMATERIALS AS PROTEOGLYCAN MIMETICS
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
ES2769059T3 (es) 2017-05-12 2020-06-24 Farco Gmbh Composición de instilación de la vejiga que contiene sulfato de condonitina (20 mg/ml), ácido hialurónico (16 mg/ml) y buffer de fosfato (pH 6,1 a 7,9) con mayor estabilidad de almacenamiento para el tratamiento de la cistitis
CN114748635B (zh) * 2020-12-25 2024-07-09 姜秉均 含有疏水性物质的纳米组成物及其制备方法与用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971955A (en) † 1981-03-02 1990-11-20 Soll David B Protection of human and animal cells during surgical trauma
US4486416A (en) † 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma
AU555747B2 (en) * 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
JPS6147418A (ja) * 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
DE69017559T3 (de) * 1989-07-24 2002-06-06 Allergan Pharmaceuticals (Ireland) Ltd., Irvine Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu.
US5627162A (en) † 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
JPH0662425B2 (ja) * 1992-12-02 1994-08-17 生化学工業株式会社 ヒアルロン酸含有血中脂質低下剤
US5952006A (en) † 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US6984667B2 (en) † 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
ATE264674T1 (de) † 1998-10-22 2004-05-15 Bioniche Life Sciences Inc Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
CA2269260C (en) † 1999-04-16 2002-12-31 Stellar International Inc. Treatment of cystitis with chondroitin sulfate
US6083933A (en) † 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
AU2001281368B2 (en) † 2000-07-31 2005-07-28 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
JP2003201257A (ja) * 2001-11-05 2003-07-18 Seikagaku Kogyo Co Ltd 上皮膨隆用の医療用組成物
US6780841B2 (en) † 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
AU2003295347B2 (en) 2002-10-16 2010-02-11 Arthrodynamic Holdings, Llc Treatment for traumatic synovitis and damaged articular cartilage
JP2004137183A (ja) * 2002-10-17 2004-05-13 Kotobuki Seiyaku Kk グリコサミノグリカン又はその塩を含む経口投与用医薬品、健康食品又は栄養薬品組成物
JP4143387B2 (ja) * 2002-11-21 2008-09-03 株式会社アセロラフーズ 健康食品
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
JP2004359554A (ja) * 2003-06-02 2004-12-24 Spirulina Biological Lab Ltd 老化防止剤及び皮膚外用剤
CN101031310B (zh) † 2004-09-28 2010-10-27 千寿制药株式会社 含有黄原胶和氨基酸的眼科用组合物

Also Published As

Publication number Publication date
EP2034956A1 (en) 2009-03-18
CA2653369A1 (en) 2007-12-06
ES2664951T3 (es) 2018-04-24
FI2034956T4 (fi) 2023-08-31
EP2034956B2 (en) 2023-06-28
TR201808687T4 (tr) 2018-07-23
ITMI20061030A1 (it) 2007-11-27
DK2034956T4 (da) 2023-07-24
WO2007138014A1 (en) 2007-12-06
US8252770B2 (en) 2012-08-28
DK2034956T3 (en) 2018-05-22
CA2653369C (en) 2015-11-17
PL2034956T5 (pl) 2023-08-07
JP5177446B2 (ja) 2013-04-03
US20090181924A1 (en) 2009-07-16
ES2664951T5 (es) 2023-09-27
EP2034956B1 (en) 2018-03-21
HUE037542T2 (hu) 2018-09-28
JP2009538287A (ja) 2009-11-05

Similar Documents

Publication Publication Date Title
HUE037542T2 (hu) Alacsony viszkozitású glükózaminoglikánokat tartalmazó készítmények és alkalmazásuk krónikus hólyaggyulladás kezelésére
GB0703968D0 (en) Improvements in and relating to medicinal compositions
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
ZA200805763B (en) Cationic steroid antimicrobial compositions and methods of use
IL218257A (en) A solid pharmaceutical preparation containing sglt-2 inhibitor and metformin and this drug for the treatment of metabolic disorders
EP2035014A4 (en) FUCOIDANE PREPARATIONS AND METHODS
IL194699A (en) Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
GB2447522B (en) Synergistic preservetive systems and their use in topical compositions
PT2296670E (pt) Utilização oral de glicosaminoglicana e composições
GB0703966D0 (en) Improvements in or relating to medicinal compositions
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
GB0703967D0 (en) Improvements in or relating to medicinal compositions
EP2370068A4 (en) METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
GB0702875D0 (en) Synergistic preservitive systems and thier use in cosmetic compositions
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
PT2308497E (pt) Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas
GB0703933D0 (en) Improvements in or relating to medicinal compositions
EP2029132A4 (en) ANTIHISTAMINE COMPOSITIONS AND THEIR USE
SI2136771T1 (sl) Sestavki, ki vsebujejo N-acetilglukozamin, za uporabo v dermokozmetologiji in estetski medicini
GB0720600D0 (en) Representation of communicatons sessions in virtual environments
IL197236A (en) Pharmaceuticals containing Almatosumab and uses of Almatosumab for the preparation of pharmaceuticals to reduce the risk of MS
PL2003977T3 (pl) Zestaw i kompozycja do impregnacji wyrobów celulozowych
PT2155161T (pt) Composição líquida estável de sulfato de condroitina e glucosamina